NCT02650635 2018-09-05TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsMayo ClinicPhase 1 Terminated4 enrolled
NCT01334177 2015-03-05TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckUniversity of WashingtonPhase 1 Completed13 enrolled